Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Vile

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Journal of Virology|April 3, 1998
A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequencesH Chong, W Starkey, R G Vile
Molecular Biotechnology|April 1, 1996
Retroviral vectors. From laboratory tools to molecular medicineR G Vile, A Tuszynski, S Castleden
Advanced Drug Delivery Reviews|November 10, 2000
Transcriptional control: an essential component of cancer gene therapy strategies?K J Harrington, E Linardakis, R G Vile
Glycoconjugate Journal|February 1, 1996
Selectin ligands on human melanoma cellsN Miller, R G Vile, I R Hart
Molecular Medicine Today|April 21, 1998
Strategies for achieving multiple layers of selectivity in gene therapyR G Vile, K Sunassee, R M Diaz
The British Journal of Surgery|May 1, 1993
Gene transfer therapy in cancerS Dorudi, J M Northover, R G Vile
Gene Therapy|August 3, 2000
Feeding dendritic cells with tumor antigens: self-service buffet or à la carte?I Melero, R G Vile, M P Colombo
Melanoma Research|April 1, 1995
Effects of modulators of tyrosinase activity on expression of murine interleukin-2 cDNA driven by the tyrosinase promoterN Miller, R G Vile, I R Hart
Gene Therapy|February 19, 2000
Cancer gene therapy: hard lessons and new coursesR G Vile, S J Russell, N R Lemoine
BMJ (Clinical Research Ed.)|January 23, 1998
Gene therapy for cancer--managing expectationsA A Melcher, I Garcia-Ribas, R G Vile
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Journal of Virology|April 3, 1998
A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequencesH Chong, W Starkey, R G Vile
Molecular Biotechnology|April 1, 1996
Retroviral vectors. From laboratory tools to molecular medicineR G Vile, A Tuszynski, S Castleden
Advanced Drug Delivery Reviews|November 10, 2000
Transcriptional control: an essential component of cancer gene therapy strategies?K J Harrington, E Linardakis, R G Vile
Glycoconjugate Journal|February 1, 1996
Selectin ligands on human melanoma cellsN Miller, R G Vile, I R Hart
Molecular Medicine Today|April 21, 1998
Strategies for achieving multiple layers of selectivity in gene therapyR G Vile, K Sunassee, R M Diaz
The British Journal of Surgery|May 1, 1993
Gene transfer therapy in cancerS Dorudi, J M Northover, R G Vile
Gene Therapy|August 3, 2000
Feeding dendritic cells with tumor antigens: self-service buffet or à la carte?I Melero, R G Vile, M P Colombo
Melanoma Research|April 1, 1995
Effects of modulators of tyrosinase activity on expression of murine interleukin-2 cDNA driven by the tyrosinase promoterN Miller, R G Vile, I R Hart
Gene Therapy|February 19, 2000
Cancer gene therapy: hard lessons and new coursesR G Vile, S J Russell, N R Lemoine
BMJ (Clinical Research Ed.)|January 23, 1998
Gene therapy for cancer--managing expectationsA A Melcher, I Garcia-Ribas, R G Vile
Pageof 9